Bronchopulmonary dysplasia, or BPD, is a serious lung condition that affects mostly babies who are born more than 8 weeks before their due date, weigh less than 3 1/2 pounds, and have breathing problems at birth. However, BPD can affect any baby born more than 4 weeks early.
Bronchopulmonary dysplasia (BPD) is a lung disorder that affects premature babies with underdeveloped lungs. Oxygen therapy damages their lungs over time.
Bronchopulmonary dysplasia (BPD; also known as neonatal chronic lung disease [CLD]) is a major cause of respiratory illness in preterm infants. It is an important contributing factor in the increased risk of mortality and morbidity in the preterm population.
Bronchopulmonary dysplasia (BPD) is a serious lung condition in newborns that develops as a complication of another breathing condition. Learn more about the causes, risk factors, complications, treatments, and life after BPD.
Bronchopulmonary dysplasia (BPD), also known as chronic lung disease of prematurity (CLD), is a common, yet serious condition that occurs in premature babies. Babies born prematurely often have underdeveloped, fragile lungs, and require support to breathe.
Bronchopulmonary dysplasia (BPD) is a form of chronic lung disease that affects newborns, most often those who are born prematurely and need oxygen therapy. In BPD the lungs and the airways (bronchi) are damaged, causing tissue destruction (dysplasia) in the tiny air sacs of the lung (alveoli).
Bronchopulmonary dysplasia (BPD) is also known as preterm lung disease. It is a condition that babies may be born with or develop soon after birth. Babies with BPD have swelling in their lungs and airways. This makes it harder for them to breathe.